GRDN
Guardian Pharmacy Services, Inc.
Price Chart
Latest Quote
$39.19
| Previous Close | $41.89 |
| Open | $40.90 |
| Day High | $41.10 |
| Day Low | $39.04 |
| Volume | 477,299 |
Stock Information
| Shares Outstanding | 49.78M |
| Total Debt | $41.19M |
| Cash Equivalents | $64.89M |
| Revenue | $1.46B |
| Net Income | $53.07M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $2.48B |
| P/E Ratio | 46.65 |
| EPS (TTM) | $0.84 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.47B |
| Sales | $1.46B |
| Income | $53.07M |
| Book/sh | $3.49 |
| Cash/sh | $1.30 |
| Employees | 4K |
Financial Ratios
| Quick Ratio | 1.10 |
| Current Ratio | 1.47 |
| Debt/Eq | 17.72 |
| EPS Growth TTM | 40.70% |
Returns & Margins
| ROA | 14.43% |
| ROE | 26.91% |
| Gross Margin | 20.93% |
| Operating Margin | 6.20% |
| Profit Margin | 3.65% |
Ownership
| Insider Ownership | 37.52% |
| Institutional Ownership | 58.22% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 28.85 |
| P/S | 1.70 |
| P/B | 11.24 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $47.00 |
Technical Indicators
| SMA20 | $40.82 |
| SMA50 | $38.51 |
| SMA200 | $32.47 |
| RSI | 51.27 |
| ATR | 1.6557 |
| Shares Float | 31.99M |
| Short Float | 7.85% |
| Short Ratio | 7.13 |
| Rel Volume | 1.15 |
Performance History
| Week | -8.61% |
| Month | +2.14% |
| Quarter | +5.18% |
| 6 Months | +25.81% |
| YTD | +32.71% |
| Year | +94.98% |
| 10 Years | +144.94% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $39.19 | 477,300 |
| 2026-06-22 | $41.89 | 423,400 |
| 2026-06-18 | $42.41 | 1,002,700 |
| 2026-06-17 | $43.40 | 281,600 |
| 2026-06-16 | $42.42 | 377,300 |
| 2026-06-15 | $42.88 | 276,200 |
| 2026-06-12 | $43.09 | 305,700 |
| 2026-06-11 | $43.08 | 306,700 |
| 2026-06-10 | $41.97 | 412,600 |
| 2026-06-09 | $41.83 | 308,500 |
| 2026-06-08 | $40.51 | 309,500 |
| 2026-06-05 | $40.48 | 445,200 |
| 2026-06-04 | $40.80 | 494,900 |
| 2026-06-03 | $39.14 | 349,100 |
| 2026-06-02 | $38.92 | 499,600 |
| 2026-06-01 | $39.26 | 407,300 |
| 2026-05-29 | $38.74 | 591,600 |
| 2026-05-28 | $38.75 | 361,400 |
| 2026-05-27 | $39.12 | 272,100 |
| 2026-05-26 | $38.59 | 384,900 |
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
đ° Latest News
AMNEAL PHARMACEUTICALS, INC. (AMRX) Hits Fresh High: Is There Still Room to Run?
Zacks âĸ 2026-06-11T13:15:03ZGuardian Pharmacy Services, Inc. (GRDN) Hit a 52 Week High, Can the Run Continue?
Zacks âĸ 2026-06-08T13:15:04ZStatutory Profit Doesn't Reflect How Good Guardian Pharmacy Services' (NYSE:GRDN) Earnings Are
Simply Wall St. âĸ 2026-05-14T11:28:53ZGuardian Pharmacy Services Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-10T17:14:45ZThe Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Strong Q1 Beat And New Shelf Registration
Simply Wall St. âĸ 2026-05-10T04:23:50ZGuardian Pharmacy Services, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T12:30:00ZGuardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates
Zacks âĸ 2026-05-07T01:45:05ZGuardian Pharmacy Services to Report Q1 Earnings: What's in the Cards?
Zacks âĸ 2026-05-01T13:28:00ZStevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth
Zacks âĸ 2026-04-30T14:00:11ZGuardian Pharmacy Services (GRDN) Reports Next Week: Wall Street Expects Earnings Growth
Zacks âĸ 2026-04-29T14:00:31ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,155,967,000 | $984,038,000 | $837,883,000 | $723,043,000 |
| Cost Of Revenue | $1,155,967,000 | $984,038,000 | $837,883,000 | $723,043,000 |
| Total Revenue | $1,448,685,000 | $1,228,409,000 | $1,046,193,000 | $908,909,000 |
| Operating Revenue | $1,448,685,000 | $1,228,409,000 | $1,046,193,000 | $908,909,000 |
| Expenses | ||||
| Interest Expense | $665,000 | $3,278,000 | $2,859,000 | $1,926,000 |
| Total Expenses | $1,375,984,000 | $1,291,329,000 | $1,005,247,000 | $856,919,000 |
| Other Income Expense | $1,387,000 | $-279,000 | $-367,000 | $-403,000 |
| Other Non Operating Income Expenses | $1,387,000 | $-279,000 | $-367,000 | $-403,000 |
| Net Non Operating Interest Income Expense | $-665,000 | $-3,278,000 | $-2,859,000 | $-1,926,000 |
| Interest Expense Non Operating | $665,000 | $3,278,000 | $2,859,000 | $1,926,000 |
| Operating Expense | $220,017,000 | $307,291,000 | $167,364,000 | $133,876,000 |
| Other Operating Expenses | - | - | - | $-3,381,000 |
| Selling And Marketing Expense | - | - | - | $137,257,000 |
| General And Administrative Expense | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $49,219,000 | $-87,287,000 | $23,902,000 | $35,421,000 |
| Net Interest Income | $-665,000 | $-3,278,000 | $-2,859,000 | $-1,926,000 |
| Normalized Income | $49,219,000 | $-87,287,000 | $23,902,000 | $35,421,000 |
| Net Income From Continuing And Discontinued Operation | $49,219,000 | $-87,287,000 | $23,902,000 | $35,421,000 |
| Total Operating Income As Reported | $72,701,000 | $-62,920,000 | $40,946,000 | $51,990,000 |
| Net Income Common Stockholders | $49,219,000 | $-110,047,000 | $0 | $35,421,000 |
| Net Income | $49,219,000 | $-87,287,000 | $23,902,000 | $35,421,000 |
| Net Income Including Noncontrolling Interests | $48,958,000 | $-71,033,000 | $37,720,000 | $49,661,000 |
| Net Income Continuous Operations | $48,958,000 | $-71,033,000 | $37,720,000 | $49,661,000 |
| Pretax Income | $73,423,000 | $-66,477,000 | $37,720,000 | $49,661,000 |
| Operating Income | $72,701,000 | $-62,920,000 | $40,946,000 | $51,990,000 |
| Gross Profit | $292,718,000 | $244,371,000 | $208,310,000 | $185,866,000 |
| Per Share | ||||
| Diluted EPS | $0.78 | $-1.77 | $0.00 | $0.58 |
| Basic EPS | $0.79 | $-1.77 | $0.00 | $0.58 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $96,423,000 | $-43,427,000 | $58,813,000 | $68,150,000 |
| Reconciled Depreciation | $22,335,000 | $19,772,000 | $18,234,000 | $16,563,000 |
| EBITDA (Bullshit earnings) | $96,423,000 | $-43,427,000 | $58,813,000 | $68,150,000 |
| EBIT | $74,088,000 | $-63,199,000 | $40,579,000 | $51,587,000 |
| Diluted Average Shares | $63,297,123 | $62,005,811 | $60,844,123 | $60,844,123 |
| Basic Average Shares | $62,386,253 | $62,005,811 | $60,844,123 | $60,844,123 |
| Diluted NI Availto Com Stockholders | $49,219,000 | $-110,047,000 | $0 | $35,421,000 |
| Otherunder Preferred Stock Dividend | $0 | $22,760,000 | $23,902,000 | - |
| Minority Interests | $261,000 | $-16,254,000 | $-13,818,000 | $-14,240,000 |
| Tax Provision | $24,465,000 | $4,556,000 | $0 | - |
| Selling General And Administration | $220,017,000 | $307,291,000 | $167,364,000 | $133,876,000 |
| Salaries And Wages | - | - | - | - |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $107,541,000 | $58,463,000 | $-68,025,000 | $-70,488,000 |
| Total Assets | $412,658,000 | $320,810,000 | $271,165,000 | $256,114,000 |
| Total Non Current Assets | $191,024,000 | $168,825,000 | $141,560,000 | $136,116,000 |
| Other Non Current Assets | $436,000 | $383,000 | $358,000 | $435,000 |
| Non Current Deferred Assets | $2,199,000 | $5,272,000 | $0 | - |
| Non Current Deferred Taxes Assets | $2,199,000 | $5,272,000 | $0 | - |
| Goodwill And Other Intangible Assets | $98,218,000 | $84,208,000 | $68,025,000 | $70,488,000 |
| Other Intangible Assets | $18,475,000 | $14,912,000 | $11,979,000 | $14,442,000 |
| Current Assets | $221,634,000 | $151,985,000 | $129,605,000 | $119,998,000 |
| Other Current Assets | $11,042,000 | $9,622,000 | $14,864,000 | $10,123,000 |
| Inventory | $43,359,000 | $40,550,000 | $36,727,000 | $41,443,000 |
| Receivables | $101,614,000 | $97,153,000 | $77,262,000 | $67,825,000 |
| Accounts Receivable | $101,614,000 | $97,153,000 | $77,262,000 | $67,825,000 |
| Allowance For Doubtful Accounts Receivable | $-8,712,000 | $-8,868,000 | $-6,171,000 | - |
| Gross Accounts Receivable | $110,326,000 | $106,021,000 | $83,433,000 | - |
| Cash Cash Equivalents And Short Term Investments | $65,619,000 | $4,660,000 | $752,000 | $607,000 |
| Cash And Cash Equivalents | $65,619,000 | $4,660,000 | $752,000 | $607,000 |
| Debt | ||||
| Total Debt | $37,142,000 | $30,133,000 | $61,001,000 | $56,814,000 |
| Long Term Debt And Capital Lease Obligation | $29,992,000 | $23,297,000 | $41,795,000 | $43,310,000 |
| Current Debt And Capital Lease Obligation | $7,150,000 | $6,836,000 | $19,206,000 | $13,504,000 |
| Net Debt | - | - | $31,217,000 | $30,326,000 |
| Long Term Debt | - | - | $18,992,000 | $22,969,000 |
| Current Debt | - | - | $12,977,000 | $7,964,000 |
| Other Current Borrowings | - | - | $3,977,000 | $3,964,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $194,734,000 | $170,834,000 | $211,306,000 | $180,185,000 |
| Total Non Current Liabilities Net Minority Interest | $34,031,000 | $26,713,000 | $73,291,000 | $68,180,000 |
| Other Non Current Liabilities | $4,039,000 | $3,416,000 | $31,496,000 | $24,870,000 |
| Current Liabilities | $160,703,000 | $144,121,000 | $138,015,000 | $112,005,000 |
| Other Current Liabilities | $22,299,000 | $20,435,000 | $16,245,000 | $6,453,000 |
| Payables And Accrued Expenses | $116,206,000 | $102,420,000 | $85,603,000 | $78,101,000 |
| Payables | $116,206,000 | $102,420,000 | $85,603,000 | $78,101,000 |
| Accounts Payable | $116,206,000 | $102,420,000 | $85,603,000 | $78,101,000 |
| Dividends Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $205,759,000 | $142,671,000 | $28,209,000 | $42,729,000 |
| Total Equity Gross Minority Interest | $217,924,000 | $149,976,000 | $59,859,000 | $75,929,000 |
| Stockholders Equity | $205,759,000 | $142,671,000 | $0 | $0 |
| Retained Earnings | $66,343,000 | $17,124,000 | - | - |
| Gains Losses Not Affecting Retained Earnings | - | - | - | $0 |
| Other | ||||
| Ordinary Shares Number | $63,320,634 | $63,287,158 | $60,844,123 | $60,844,123 |
| Share Issued | $63,320,634 | $63,287,158 | $60,844,123 | $60,844,123 |
| Tangible Book Value | $107,541,000 | $58,463,000 | $-39,816,000 | $-27,759,000 |
| Invested Capital | $205,759,000 | $142,671,000 | $60,178,000 | $73,662,000 |
| Working Capital | $60,931,000 | $7,864,000 | $-8,410,000 | $7,993,000 |
| Capital Lease Obligations | $37,142,000 | $30,133,000 | $29,032,000 | $25,881,000 |
| Total Capitalization | $205,759,000 | $142,671,000 | $47,201,000 | $65,698,000 |
| Minority Interest | $12,165,000 | $7,305,000 | $31,650,000 | $33,200,000 |
| Additional Paid In Capital | $139,353,000 | $125,484,000 | - | - |
| Capital Stock | $63,000 | $63,000 | - | - |
| Common Stock | $63,000 | $63,000 | - | - |
| Long Term Capital Lease Obligation | $29,992,000 | $23,297,000 | $22,803,000 | $20,341,000 |
| Current Capital Lease Obligation | $7,150,000 | $6,836,000 | $6,229,000 | $5,540,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $15,048,000 | $14,430,000 | $16,961,000 | $13,947,000 |
| Goodwill | $79,743,000 | $69,296,000 | $56,046,000 | $56,046,000 |
| Net PPE | $90,171,000 | $78,962,000 | $73,177,000 | $65,193,000 |
| Accumulated Depreciation | $-87,845,000 | $-77,980,000 | $-68,924,000 | $-60,801,000 |
| Gross PPE | $178,016,000 | $156,942,000 | $142,101,000 | $125,994,000 |
| Leases | $22,390,000 | $17,345,000 | $14,043,000 | $12,287,000 |
| Other Properties | $111,138,000 | $97,714,000 | $88,619,000 | $79,284,000 |
| Machinery Furniture Equipment | $44,488,000 | $41,883,000 | $39,439,000 | $34,423,000 |
| Properties | $0 | $0 | $0 | $0 |
| Line Of Credit | - | $0 | $9,000,000 | $4,000,000 |
| Total Partnership Capital | - | - | $28,209,000 | $42,729,000 |
| Limited Partnership Capital | - | - | $28,209,000 | $42,729,000 |
| Employee Benefits | - | - | - | $21,361,000 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $80,710,000 | $41,592,000 | $56,263,000 | $31,752,000 |
| Operating Activities | ||||
| Operating Cash Flow | $100,255,000 | $57,960,000 | $70,819,000 | $48,522,000 |
| Cash Flow From Continuing Operating Activities | $100,255,000 | $57,960,000 | $70,819,000 | $48,522,000 |
| Investing Activities | ||||
| Capital Expenditure | $-19,545,000 | $-16,368,000 | $-14,556,000 | $-16,770,000 |
| Investing Cash Flow | $-32,225,000 | $-30,407,000 | $-13,441,000 | $-17,899,000 |
| Cash Flow From Continuing Investing Activities | $-32,225,000 | $-30,407,000 | $-13,441,000 | $-17,899,000 |
| Net Other Investing Changes | $736,000 | $671,000 | $2,100,000 | $874,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-29,039,000 | $-55,176,000 | $0 | - |
| Issuance Of Capital Stock | $29,039,000 | $119,784,000 | $0 | - |
| Financing Cash Flow | $-7,071,000 | $-23,645,000 | $-57,233,000 | $-45,028,000 |
| Cash Flow From Continuing Financing Activities | $-7,071,000 | $-23,645,000 | $-57,233,000 | $-45,028,000 |
| Net Other Financing Charges | $-2,091,000 | $-16,022,000 | $-15,918,000 | $-11,422,000 |
| Cash Dividends Paid | $0 | $-35,750,000 | $-38,422,000 | $-30,804,000 |
| Common Stock Dividend Paid | $0 | $-35,750,000 | $-38,422,000 | $-30,804,000 |
| Net Common Stock Issuance | $0 | $64,608,000 | $0 | - |
| Common Stock Issuance | $29,039,000 | $119,784,000 | $0 | - |
| Other | ||||
| Repayment Of Debt | $-4,980,000 | $-240,781,000 | $-272,393,000 | $-255,802,000 |
| Issuance Of Debt | $0 | $204,300,000 | $269,500,000 | $253,000,000 |
| Interest Paid Supplemental Data | $650,000 | $3,121,000 | $2,783,000 | $1,779,000 |
| Income Tax Paid Supplemental Data | $21,541,000 | $0 | - | - |
| End Cash Position | $65,619,000 | $4,660,000 | $752,000 | $607,000 |
| Beginning Cash Position | $4,660,000 | $752,000 | $607,000 | $15,012,000 |
| Changes In Cash | $60,959,000 | $3,908,000 | $145,000 | $-14,405,000 |
| Common Stock Payments | $-29,039,000 | $-55,176,000 | $0 | - |
| Net Issuance Payments Of Debt | $-4,980,000 | $-36,481,000 | $-2,893,000 | $-2,802,000 |
| Net Short Term Debt Issuance | $0 | $-9,000,000 | $5,000,000 | $4,000,000 |
| Short Term Debt Payments | $0 | $-198,300,000 | $-264,500,000 | $-249,000,000 |
| Short Term Debt Issuance | $0 | $189,300,000 | $269,500,000 | $253,000,000 |
| Net Long Term Debt Issuance | $-4,980,000 | $-27,481,000 | $-7,893,000 | $-6,802,000 |
| Long Term Debt Payments | $-4,980,000 | $-42,481,000 | $-7,893,000 | $-6,802,000 |
| Long Term Debt Issuance | $0 | $15,000,000 | $0 | - |
| Net Business Purchase And Sale | $-13,416,000 | $-14,710,000 | $-985,000 | $-2,003,000 |
| Purchase Of Business | $-13,416,000 | $-14,710,000 | $-985,000 | $-2,003,000 |
| Net PPE Purchase And Sale | $-19,545,000 | $-16,368,000 | $-14,556,000 | $-16,770,000 |
| Purchase Of PPE | $-19,545,000 | $-16,368,000 | $-14,556,000 | $-16,770,000 |
| Change In Working Capital | $6,382,000 | $-29,406,000 | $15,602,000 | $-18,719,000 |
| Change In Other Current Liabilities | $1,278,000 | $-11,054,000 | $20,852,000 | $-4,446,000 |
| Change In Other Current Assets | $-2,482,000 | $-1,979,000 | $-4,688,000 | $-1,574,000 |
| Change In Payables And Accrued Expense | $17,016,000 | $10,263,000 | $9,308,000 | $12,218,000 |
| Change In Accrued Expense | $618,000 | $-2,967,000 | $3,013,000 | $-1,148,000 |
| Change In Payable | $16,398,000 | $13,230,000 | $6,295,000 | $13,366,000 |
| Change In Account Payable | $16,398,000 | $13,230,000 | $6,295,000 | $13,366,000 |
| Change In Inventory | $-877,000 | $-1,151,000 | $4,426,000 | $-8,123,000 |
| Change In Receivables | $-8,553,000 | $-25,485,000 | $-14,296,000 | $-16,794,000 |
| Changes In Account Receivables | $-8,553,000 | $-25,485,000 | $-14,296,000 | $-16,794,000 |
| Other Non Cash Items | $1,075,000 | $767,000 | $283,000 | $257,000 |
| Stock Based Compensation | $13,850,000 | $131,490,000 | $-6,090,000 | $-3,381,000 |
| Provisionand Write Offof Assets | $4,581,000 | $6,370,000 | $5,070,000 | $4,141,000 |
| Deferred Tax | $3,074,000 | $0 | - | - |
| Deferred Income Tax | $3,074,000 | $0 | - | - |
| Depreciation Amortization Depletion | $22,335,000 | $19,772,000 | $18,234,000 | $16,563,000 |
| Depreciation And Amortization | $22,335,000 | $19,772,000 | $18,234,000 | $16,563,000 |
| Amortization Cash Flow | $3,658,000 | $3,302,000 | $3,068,000 | $3,367,000 |
| Amortization Of Intangibles | $3,658,000 | $3,302,000 | $3,068,000 | $3,367,000 |
| Depreciation | $18,677,000 | $16,470,000 | $15,166,000 | $13,196,000 |
| Net Income From Continuing Operations | $48,958,000 | $-71,033,000 | $37,720,000 | $49,661,000 |
| Change In Other Working Capital | - | - | - | $-1,148,000 |